{
  "cik": 1690585,
  "cik_padded": "0001690585",
  "entityName": "Dianthus Therapeutics, Inc. /DE/",
  "fiscal_years": [
    {
      "accn": "0001690585-26-000006",
      "filed": "2026-03-09",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 51087000.0,
        "eps_diluted": -4.2,
        "net_income": -162337000.0,
        "operating_cash_flow": -129060000.0,
        "operating_income": -177933000.0,
        "revenue": 2036000.0,
        "stockholders_equity": 493401000.0,
        "total_assets": 530922000.0,
        "total_liabilities": 37521000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.07604565049523612,
        "revenue_growth_yoy": -0.6734562951082598,
        "roa_avg2y": -0.3587835523189639,
        "roa_period_end": -0.30576431189515596,
        "roe_avg2y": -0.3838307651930893,
        "roe_period_end": -0.3290163578914514
      }
    },
    {
      "accn": "0001690585-26-000006",
      "filed": "2026-03-09",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 22792000.0,
        "eps_diluted": -2.55,
        "net_income": -84969000.0,
        "operating_cash_flow": -78180000.0,
        "operating_income": -101864000.0,
        "revenue": 6235000.0,
        "stockholders_equity": 352477000.0,
        "total_assets": 374008000.0,
        "total_liabilities": 21531000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.061084836741120696,
        "revenue_growth_yoy": 1.2062986553432413,
        "roa_avg2y": -0.30707265640669806,
        "roa_period_end": -0.22718498000042783,
        "roe_avg2y": -0.32595948571680666,
        "roe_period_end": -0.2410625374137887
      }
    },
    {
      "accn": "0001690585-26-000006",
      "filed": "2026-03-09",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 132325000.0,
        "eps_diluted": -8.45,
        "net_income": -43555000.0,
        "operating_cash_flow": -36861000.0,
        "operating_income": -48174000.0,
        "revenue": 2826000.0,
        "stockholders_equity": 168870000.0,
        "total_assets": 179405000.0,
        "total_liabilities": 10535000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.062385266773257536,
        "roa_avg2y": -0.33182865741005274,
        "roa_period_end": -0.24277472757169533,
        "roe_avg2y": -0.6996674752212816,
        "roe_period_end": -0.25792029371706043
      }
    },
    {
      "accn": "0000950170-25-037131",
      "filed": "2025-03-11",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 15365000.0,
        "eps_diluted": -32.57,
        "net_income": -28476000.0,
        "operating_cash_flow": -29070000.0,
        "operating_income": -29705000.0,
        "stockholders_equity": -44368000.0,
        "total_assets": 83110000.0,
        "total_liabilities": 9454000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.20858176704120948,
        "roa_period_end": -0.3426302490675009,
        "roe_avg2y": 0.9242903744096597
      }
    },
    {
      "accn": "0000950170-24-034681",
      "filed": "2024-03-21",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 131650000.0,
        "eps_diluted": -1.29,
        "net_income": -71136000.0,
        "operating_cash_flow": -59531000.0,
        "operating_income": -74692000.0,
        "stockholders_equity": -17249000.0,
        "total_assets": 189934000.0,
        "total_liabilities": 17262000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.4046957357781046,
        "roa_period_end": -0.3745300999294492,
        "roe_avg2y": -1.123285724436865
      }
    },
    {
      "accn": "0001193125-22-068759",
      "filed": "2023-03-23",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 58152000.0,
        "eps_diluted": -1.71,
        "net_income": -74936000.0,
        "operating_cash_flow": -64023000.0,
        "operating_income": -78702000.0,
        "stockholders_equity": 143906000.0,
        "total_assets": 161619000.0,
        "total_liabilities": 17713000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1230872930941031,
        "roa_avg2y": -0.46380901981537015,
        "roa_period_end": -0.46365835700010516,
        "roe_avg2y": -0.525684060624555,
        "roe_period_end": -0.5207288090837074
      }
    },
    {
      "accn": "0001193125-22-068759",
      "filed": "2022-03-08",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 65071000.0,
        "net_income": -76769000.0,
        "operating_cash_flow": -57103000.0,
        "operating_income": -82969000.0,
        "stockholders_equity": 141193000.0,
        "total_assets": 161514000.0,
        "total_liabilities": 20321000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.14392356561585914,
        "roa_avg2y": -0.4815715105684274,
        "roa_period_end": -0.4753086419753087,
        "roe_avg2y": -0.535272154259677,
        "roe_period_end": -0.5437167564964269
      }
    },
    {
      "accn": "0001193125-21-066707",
      "filed": "2021-03-03",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 58345000.0,
        "net_income": -57515000.0,
        "operating_cash_flow": -41886000.0,
        "operating_income": -59963000.0,
        "stockholders_equity": 145648000.0,
        "total_assets": 157313000.0,
        "total_liabilities": 11665000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.08009035482807865,
        "roa_avg2y": -0.5431682532487156,
        "roa_period_end": -0.36560869095370374,
        "roe_avg2y": -1.1110789143243505,
        "roe_period_end": -0.3948904207404153
      }
    },
    {
      "accn": "0001193125-20-059835",
      "filed": "2020-03-03",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 51402000.0,
        "net_income": -35491000.0,
        "operating_cash_flow": -22263000.0,
        "operating_income": -35727000.0,
        "stockholders_equity": -42118000.0,
        "total_assets": 54463000.0,
        "total_liabilities": 4142000.0
      },
      "period_end": "2017-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.6516534160806419,
        "roe_avg2y": 1.392022278004393
      }
    },
    {
      "accn": "0001193125-20-059835",
      "filed": "2020-03-03",
      "fiscal_year": 2016,
      "form": "10-K",
      "fundamental_units": {
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "net_income": -9431000.0,
        "operating_cash_flow": -6529000.0,
        "operating_income": -9268000.0,
        "stockholders_equity": -8874000.0
      },
      "period_end": "2016-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001690585-26-000006",
    "filed": "2026-03-09",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001690585.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001690585.json"
  },
  "ticker": "DNTH"
}